Rivaroxaban Versus Vitamin K Antagonist in Antiphospholipid Syndrome

2019
Long-term anticoagulation with vitamin K antagonists (VKAs) is the standard of care for preventing thrombosis in patients with antiphospholipid antibody syndrome (APS), but VKAs require frequent mo...
    • Correction
    • Source
    • Cite
    • Save
    0
    References
    3
    Citations
    NaN
    KQI
    []
    Baidu
    map